Issues related to pharmacy, Medicare Part D, and prescription drug pricing policy.
2025 · 2nd Quarter (Apr 1 - June 30)
CIGNA CORPORATION AND SUBSIDIARIES
Filed by TIBER CREEK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2025
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Filing UUID
- 477e38bf-6ce6-4cbd-b5ac-691d626ba4e4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability. Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21).
Pharmacy issues related to TRICARE.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.